Evaluation of antibiofilm activity of cefiderocol alone and in combination with imipenem against Pseudomonas aeruginosa

•Biofilm-related infections caused by Pseudomonas aeruginosa are a critical problem.•Cefiderocol is a new siderophore cephalosporin targeting Gram-negative bacteria.•Cefiderocol and imipenem showed synergistic activity vs. biofilm in vitro.•Cefiderocol/imipenem is a valid option for the treatment of...

Full description

Saved in:
Bibliographic Details
Published inJournal of global antimicrobial resistance. Vol. 37; pp. 53 - 61
Main Authors Ferretti, Caterina, Poma, Noemi Violeta, Bernardo, Mariano, Rindi, Laura, Cesta, Novella, Tavanti, Arianna, Tascini, Carlo, Di Luca, Mariagrazia
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Ltd 01.06.2024
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:•Biofilm-related infections caused by Pseudomonas aeruginosa are a critical problem.•Cefiderocol is a new siderophore cephalosporin targeting Gram-negative bacteria.•Cefiderocol and imipenem showed synergistic activity vs. biofilm in vitro.•Cefiderocol/imipenem is a valid option for the treatment of P. aeruginosa biofilm. The main aim of this study was to evaluate the antibiofilm activity of cefiderocol alone and in combination with imipenem vs. sessile cells of Pseudomonas aeruginosa, assessing a potential synergistic bactericidal effect. Ten P. aeruginosa clinical isolates from infected implants and bloodstream were included in the study. Cefiderocol was tested alone and in combination with imipenem on 24-h-old P. aeruginosa biofilm formed on porous glass beads. For each antibiotic formulation, minimum bactericidal biofilm concentration (MBBC), defined as the lowest concentration that determined a reduction of at least 3 log10 CFU/mL compared with the untreated control, was evaluated. Scanning electron microscopy (SEM) was used to investigate the biofilm of P. aeruginosa treated with cefiderocol, imipenem, or their combination. Cefiderocol and imipenem were tested alone on P. aeruginosa biofilm and a reasonable reduction in the number of viable cells was observed, especially at high drug concentrations tested. The synergistic effect of cefiderocol in combination with imipenem was evaluated for five selected isolates. Cotreatment with the two drugs led to a remarkable reduction of cell viability by resulting in synergistic bactericidal activity in all tested strains and in synergistic eradicating activity in only one isolate. SEM analysis revealed that, in cefiderocol-treated biofilm, bacterial cells became more elongated than in the untreated control, forming filaments in which bacterial division seems to be inhibited. Cefiderocol exhibited an encouraging antibiofilm activity against tested strains, representing a valid option for the treatment of P. aeruginosa biofilm-associated infections, especially when administered in combination with imipenem.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2213-7165
2213-7173
2213-7173
DOI:10.1016/j.jgar.2024.01.021